VistaGen Therapeutics Inc - VTGN Operating Margin

VTGN (vistagen.com) - company brandmark

The massive potential of the fast-acting anxiety treatment market has created a foundation for growth for Vistagen Therapeutics (VTGN). The business's operational efficiency is reflected in current trends, where the value is fixed at -2541.90. Looking ahead, the high margins of nasal spray patents and streamlined medical sample delivery logistics will ensure stable development and a reliable supply chain for the company.

VistaGen Therapeutics, Inc. (VTGN): Operating Profit Rate from 07/04/2022 to 11/20/2026

VistaGen Therapeutics, Inc. (VTGN) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Fundamental company analysis:vistagen.com
Core merchandise of Vistagen

The market assesses the potential of Vistagen Therapeutics (VTGN) through the lens of drug development efficiency, where the estimated operating profit margin determines the business's internal profitability. An analysis of the recorded operating margin allows for a correlation between the costs of bioethical research and ESG optimization of laboratories against current revenues, classifying the asset as a high-risk instrument with a long-term investment horizon.

Main competitors

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Profitability praxismedicines.com PRAX|AVXL - Operating Sales Margin|CeriBell EEG - Operating Margin|Operating Return on Sales prothena.com|Alector Therapeutics (ALEC) - Operating Profitability|Annexon Biosciences Inc. - Operating Profit Rate|OMER (Omeros Corp) - Operating Margin|Operating Margin neurogene.com|Operating Margin ACIU|VYGR - Operating Return on Sales|Operating Profitability Neumora Therapeutics Inc NMRA|Profitability of Operations Scilex Holding Co. (SCLX)|TVGN - Operating Profitability|Operating Return on Sales alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Operating Sales Margin|IKT: Operating Profit Ratio|Operating Profitability Cassava Sciences, Inc.|ASRT (assertiotx.com) - Operating Profit Ratio|Operating Profitability Coya (COYA)|Ovid Therapeutics - Return on Sales by Operating Profit|Operating Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Operating Sales Margin|ATHE - Operating Profitability|Profitability of Operations clene.com CLNN|PEPG: Operating Margin|Return on Sales by Operating Profit JUNS|RLMD (Relmada Corp) - Operating Margin|Annovis Bio Inc (ANVS) - Profitability of Operations|Operating Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operating Profit Rate|Operating Profitability Klotho Neurosciences KLTO|NRSN: Return on Sales by Operating Profit|RVPH: Operating Sales Margin|MTVA: Operating Profitability|NRXS (NeurAxis Inc) - Operating Sales Margin|Operating Sales Margin Helius Medical Technologies, Inc.|Operating Profitability Passage Bio Inc.|Operating Return on Sales bionomics.com.au NEUP|Operating Margin NERV|Operating Margin Athira Pharma Inc (ATHA)|Operating Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Return on Sales by Operating Profit|CYCN - Operating Profitability|Operating Return on Sales Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Operating Sales Margin|Operating Profitability Margin Cortigent, Inc. CRGT|Operating Profitability Avenue Therapeutics, Inc.|Operating Sales Margin BrainStorm Cell Therapeutics Inc. (BCLI)|Operating Profitability Cara Therapeutics, Inc (CARA)|Operating Profitability CHRO (Chromocell Therapeutics Corp.)|Operating Margin ELYM (eliemtx.com)|intracellulartherapies.com - Operating Profitability|LBPH: Operating Sales Margin|Operating Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Operating Sales Margin|Operating Sales Margin NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin